Plain-English translation of NCT04594187 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Melanoma research guide โPhase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether adding radiation therapy to immunotherapy can help prevent melanoma from coming back in the lymph nodes. You have melanoma that has spread to a sentinel lymph node (the first lymph node where cancer often spreads), and your doctor has recommended immunotherapy as part of your treatment. The study will randomly assign you to receive either immunotherapy alone or immunotherapy plus radiation therapy, and follow you for up to 5 years to see which approach works better.
After surgery for melanoma with lymph node involvement, cancer sometimes comes back in nearby lymph nodes even with immunotherapy. Researchers want to know if adding radiation therapy to immunotherapy can reduce the chance of the cancer returning in these areas.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will be randomly assigned to one of two groups: one group receives immunotherapy plus radiation therapy (5 radiation treatments over 2โ2.5 weeks), and the other receives immunotherapy alone. After your treatment ends, you will have follow-up visits every 3 months for 2 years, then every 6 months for 3 years to check how you are doing and whether the cancer has returned.
AI-generated summary from trial data ยท Aug 14, 2026 ยท Not medical advice
United States